Immunology Investor Event
Sanofi was pleased to host investors and analysts for its Immunology Investor Event held in person in our new Sanofi Cambridge Headquarters in Cambridge, Massachusetts.
(16h00 CET / 10:00am EST)
Featuring
![Paul Hudson](/optim/dotcom/content-app/events/investor-presentation/2022/2022-immunology-investor-event/PHudson_20230405202911.jpg?size=small)
Paul Hudson
CEO
![Bill Sibold](/optim/dotcom/content-app/events/investor-presentation/2022/2022-immunology-investor-event/B-Sibold_20230405202911.jpg?size=small)
Bill Sibold
EVP Sanofi Specialty Care
![Brian Foard](/optim/dotcom/content-app/events/investor-presentation/2022/2022-immunology-investor-event/BrianFoard_20230405202911.jpg?size=small)
Brian Foard
Global Head of Dupixent Franchise
![Naimish Patel](/optim/dotcom/content-app/events/investor-presentation/2022/2022-immunology-investor-event/NaimishPatel_20230405202911.jpg?size=small)
Naimish Patel
Therapeutic Area Head, Immunology & Inflammation
![Frank Nestle](/optim/dotcom/content-app/events/investor-presentation/2022/2022-immunology-investor-event/FrankNestle_20230405202911.jpg?size=small)
Frank Nestle
Global Head of Research, Chief Scientific Officer
![John Reed](/optim/dotcom/content-app/events/investor-presentation/2022/2022-immunology-investor-event/J-Reed_20230405202911.jpg?size=small)
John Reed
Global Head of Research and Development